The articles listed on this page are from a variety of sources. 
1. The staff of DBS-STN often attends conferences or educational opportunities both nationally and internationally, and a brief understandable write-up of the information presented at the event will be provided for our readers to review. 
2. DBS-STN staff also identifies or writes various articles related to topics that are thought to be of interest for the reader of

Browse by Topic:

FDA Approves Rytary, Extended-Release Oral Treatment for PD

(January 9, 2015) - The US Food and Drug Administration has approved Rytary (carbidopa/levodopa), extended-release capsules for the treatment of Parkinson's disease. Rytary is expected to launch in February, 2015. Read more…

Article Archive